Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim J A Dekker

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|June 20, 2020
Therapy for HER2-Positive Metastatic Breast CancerTim J A Dekker
The New England Journal of Medicine|April 16, 2020
PARP Inhibitors in Ovarian CancerTim J A Dekker
The New England Journal of Medicine|October 14, 2022
Tirzepatide Once Weekly for the Treatment of ObesityTim J A Dekker
The New England Journal of Medicine|August 3, 2022
Oncogene Up-Regulation after Hypomethylating TherapyTim J A Dekker
The Lancet. Oncology|September 5, 2020
Ripretinib for advanced gastrointestinal stromal tumoursTim J A Dekker
The Lancet. Oncology|November 5, 2020
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutated biliary tract cancerRowan F van Golen, Tim J A Dekker
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2020
[Nitrofurantoin for uncomplicated urinary tract infections in men: should it be the first choice?]Tim J A Dekker, Anouk E Muller, Luc B S Gelinck
Nederlands Tijdschrift Voor Geneeskunde|January 16, 2015
[Loin pain haematuria syndrome]Tim J A Dekker, Kirsten V C Wevers-De Boer, Yvo W J Sijpkens
American Journal of Clinical Dermatology|November 23, 2017
Advanced Melanoma: Current Treatment Options, Biomarkers, and Future PerspectivesElisa A Rozeman, Tim J A Dekker, John B A G Haanen, et al.
Haematologica|March 5, 2026
Relapsing, steroid-refractory ICANS after CAR T-cell therapy: diagnostic work-up and response to delayed repeated intrathecal chemotherapyRosemarijn M Van Nijendaal, Joost S P Vermaat, Victor J Geraedts, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|June 20, 2020
Therapy for HER2-Positive Metastatic Breast CancerTim J A Dekker
The New England Journal of Medicine|April 16, 2020
PARP Inhibitors in Ovarian CancerTim J A Dekker
The New England Journal of Medicine|October 14, 2022
Tirzepatide Once Weekly for the Treatment of ObesityTim J A Dekker
The New England Journal of Medicine|August 3, 2022
Oncogene Up-Regulation after Hypomethylating TherapyTim J A Dekker
The Lancet. Oncology|September 5, 2020
Ripretinib for advanced gastrointestinal stromal tumoursTim J A Dekker
The Lancet. Oncology|November 5, 2020
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutated biliary tract cancerRowan F van Golen, Tim J A Dekker
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2020
[Nitrofurantoin for uncomplicated urinary tract infections in men: should it be the first choice?]Tim J A Dekker, Anouk E Muller, Luc B S Gelinck
Nederlands Tijdschrift Voor Geneeskunde|January 16, 2015
[Loin pain haematuria syndrome]Tim J A Dekker, Kirsten V C Wevers-De Boer, Yvo W J Sijpkens
American Journal of Clinical Dermatology|November 23, 2017
Advanced Melanoma: Current Treatment Options, Biomarkers, and Future PerspectivesElisa A Rozeman, Tim J A Dekker, John B A G Haanen, et al.
Haematologica|March 5, 2026
Relapsing, steroid-refractory ICANS after CAR T-cell therapy: diagnostic work-up and response to delayed repeated intrathecal chemotherapyRosemarijn M Van Nijendaal, Joost S P Vermaat, Victor J Geraedts, et al.
Pageof 3